BACKGROUND: Tuberculosis (TB) is a major cause of death worldwide. Finding an effective vaccine against TB is the best way to control it. Several vaccines against this disease have been developed but none are completely protective. The aim of this study was to design and construct a cloning vector containing the Mycobacterium tuberculosis (M. tuberculosis) heat shock protein X (hspX). METHODS: First, an hspX fragment was amplified by PCR and cloned into plasmid pcDNA3.1(+) and recombinant vector was confirmed. RESULTS: A 435 bp hspX fragment was isolated. The fragment was 100% homologous with hspX of M. tuberculosis strain H37Rv in GenBank. CONCLUSION: In this study, the cloning vector pcDNA3.1(+), containing a 435-bp hspX fragment of M. tuberculosis, was constructed. This could be used as a DNA vaccine to induce immune responses in animal models in future studies.
BACKGROUND:Tuberculosis (TB) is a major cause of death worldwide. Finding an effective vaccine against TB is the best way to control it. Several vaccines against this disease have been developed but none are completely protective. The aim of this study was to design and construct a cloning vector containing the Mycobacterium tuberculosis (M. tuberculosis) heat shock protein X (hspX). METHODS: First, an hspX fragment was amplified by PCR and cloned into plasmid pcDNA3.1(+) and recombinant vector was confirmed. RESULTS: A 435 bp hspX fragment was isolated. The fragment was 100% homologous with hspX of M. tuberculosis strain H37Rv in GenBank. CONCLUSION: In this study, the cloning vector pcDNA3.1(+), containing a 435-bp hspX fragment of M. tuberculosis, was constructed. This could be used as a DNA vaccine to induce immune responses in animal models in future studies.
Entities:
Keywords:
Cloning; DNA vaccine; Mycobacterium tuberculosis; hspX
Authors: Agatha E Wieczorek; Jolynn L Troudt; Phillip Knabenbauer; Jennifer Taylor; Rebecca L Pavlicek; Russell Karls; Anne Hess; Rebecca M Davidson; Michael Strong; Helle Bielefeldt-Ohmann; Angelo A Izzo; Karen M Dobos Journal: Pathog Dis Date: 2014-02-24 Impact factor: 3.166
Authors: Katarina Radosevic; Catharina W Wieland; Ariane Rodriguez; Gerrit Jan Weverling; Ratna Mintardjo; Gert Gillissen; Ronald Vogels; Yasir A W Skeiky; David M Hone; Jerald C Sadoff; Tom van der Poll; Menzo Havenga; Jaap Goudsmit Journal: Infect Immun Date: 2007-05-25 Impact factor: 3.441
Authors: Jennifer L Taylor; Agatha Wieczorek; Andrew R Keyser; Ajay Grover; Rachel Flinkstrom; Russell K Karls; Helle Bielefeldt-Ohmann; Karen M Dobos; Angelo A Izzo Journal: Immunol Cell Biol Date: 2012-07-17 Impact factor: 5.126
Authors: Eduardo Martins de Sousa; Adeliane Castro da Costa; Monalisa Martins Trentini; João Alves de Araújo Filho; André Kipnis; Ana Paula Junqueira-Kipnis Journal: PLoS One Date: 2012-10-25 Impact factor: 3.240